Scragg Jason L, Dallas Mark L, Wilkinson Jenny A, Varadi Gyula, Peers Chris
Division of Cardiovascular and Neuronal Remodelling, Leeds Institute of Genetics, Health, and Therapeutics, Level 10, Worsley Bldg., University of Leeds, Leeds LS2 9JT, United Kingdom.
J Biol Chem. 2008 Sep 5;283(36):24412-9. doi: 10.1074/jbc.M803037200. Epub 2008 Jul 1.
Conditions of stress, such as myocardial infarction, stimulate up-regulation of heme oxygenase (HO-1) to provide cardioprotection. Here, we show that CO, a product of heme catabolism by HO-1, directly inhibits native rat cardiomyocyte L-type Ca2+ currents and the recombinant alpha1C subunit of the human cardiac L-type Ca2+ channel. CO (applied via a recognized CO donor molecule or as the dissolved gas) caused reversible, voltage-independent channel inhibition, which was dependent on the presence of a spliced insert in the cytoplasmic C-terminal region of the channel. Sequential molecular dissection and point mutagenesis identified three key cysteine residues within the proximal 31 amino acids of the splice insert required for CO sensitivity. CO-mediated inhibition was independent of nitric oxide and protein kinase G but was prevented by antioxidants and the reducing agent, dithiothreitol. Inhibition of NADPH oxidase and xanthine oxidase did not affect the inhibitory actions of CO. Instead, inhibitors of complex III (but not complex I) of the mitochondrial electron transport chain and a mitochondrially targeted antioxidant (Mito Q) fully prevented the effects of CO. Our data indicate that the cardioprotective effects of HO-1 activity may be attributable to an inhibitory action of CO on cardiac L-type Ca2+ channels. Inhibition arises from the ability of CO to promote generation of reactive oxygen species from complex III of mitochondria. This in turn leads to redox modulation of any or all of three critical cysteine residues in the channel's cytoplasmic C-terminal tail, resulting in channel inhibition.
应激状态,如心肌梗死,会刺激血红素加氧酶(HO-1)上调以提供心脏保护作用。在此,我们表明,HO-1催化血红素分解产生的产物一氧化碳(CO)直接抑制原代大鼠心肌细胞的L型Ca2+电流以及人心脏L型Ca2+通道的重组α1C亚基。CO(通过公认的CO供体分子施加或作为溶解气体)引起可逆的、电压非依赖性通道抑制,这种抑制取决于通道胞质C末端区域中一个剪接插入片段的存在。通过序列分子剖析和点突变确定了剪接插入片段近端31个氨基酸内对于CO敏感性所需的三个关键半胱氨酸残基。CO介导的抑制与一氧化氮和蛋白激酶G无关,但可被抗氧化剂和还原剂二硫苏糖醇阻止。抑制NADPH氧化酶和黄嘌呤氧化酶并不影响CO的抑制作用。相反,线粒体电子传递链复合物III(而非复合物I)的抑制剂以及一种线粒体靶向抗氧化剂(Mito Q)可完全阻止CO的作用。我们的数据表明,HO-1活性的心脏保护作用可能归因于CO对心脏L型Ca2+通道的抑制作用。抑制作用源于CO促进线粒体复合物III产生活性氧的能力。这进而导致对通道胞质C末端尾巴中三个关键半胱氨酸残基中的任何一个或全部进行氧化还原调节,从而导致通道抑制。